{"id":49463,"date":"2022-10-11T09:02:02","date_gmt":"2022-10-11T07:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/"},"modified":"2022-10-11T09:02:02","modified_gmt":"2022-10-11T07:02:02","slug":"precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/","title":{"rendered":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress"},"content":{"rendered":"
\n

\n– Oral and Poster Presentations to Highlight Preclinical Research for ARCUS\u00ae Gene Editing<\/i>\n<\/p>\n

DURHAM, N.C.–(BUSINESS WIRE)–$DTIL<\/a> #ARCUS<\/a>–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS\u00ae-based ex vivo<\/i> allogeneic CAR T and in vivo<\/i> gene editing therapies, today announced that three abstracts have been accepted by the European Society of Gene & Cell Therapy (ESGCT) for one oral and two poster presentations at the upcoming Congress on October 11-14, 2022, at the Edinburgh International Conference Centre.\n<\/p>\n

<\/a><\/p>\n

\nOral Presentation:<\/span><\/b>\n<\/p>\n

\nTitle:<\/b> Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate Hepatitis B virus in vivo
\n
Date and Time:<\/b> Wednesday, October 12, 2022, 8:30 AM – 10:40 AM BST
\n
Session Title:<\/b> Parallel 2a, Vaccine technologies & infectious diseases
\n
Location & Poster Number:<\/b> Pentland and Sidlaw, OR14
\n
Presenter:<\/b> Derek Jantz, Ph.D., Chief Scientific Officer & Strategy\n<\/p>\n

\nPoster Presentations:<\/span><\/b>\n<\/p>\n

\nTitle:<\/b> ARCUS gene editing of Apolipoprotein C3 results in substantial reduction in serum triglycerides in vivo
\n
Date and Time:<\/b> Wednesday, October 12, 2022, 7:30 PM – 9:00 PM BST
\n
Session Title: <\/b>Gene and epigenetic editing
\n
Location & Poster Number: <\/b>Cromdale Hall, Level 2, Poster# P441
\n
Presenter:<\/b> Wendy Shoop, Scientist\n<\/p>\n

\nTitle:<\/b> Specific elimination of m.3243A>G mutant mitochondrial DNA using mitoARCUS in cultured cells and a novel xenograft mouse model
\n
Date and Time:<\/b> Thursday, October 13, 2022, 5:30 PM – 7:15 PM BST
\n
Session Title:<\/b> Gene and epigenetic editing
\n
Location & Poster Number:<\/b> Cromdale Hall, Level 2, Poster #P422
\n
Presenter:<\/b> Wendy Shoop, Scientist\n<\/p>\n

\nAbout Precision BioSciences, Inc.<\/b>\n<\/p>\n

\nPrecision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS\u00ae genome editing platform. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company\u2019s pipeline consists of multiple ex vivo \u201coff-the-shelf\u201d CAR T immunotherapy clinical candidates and several in vivo gene editing candidates designed to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Mei Burris
\n
Director, Investor Relations and Finance
\n
Mei.Burris@precisionbiosciences.com<\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Maurissa Messier
\n
Senior Director, Corporate Communications
\n
Maurissa.Messier@precisionbiosciences.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

– Oral and Poster Presentations to Highlight Preclinical Research for ARCUS\u00ae Gene Editing DURHAM, N.C.–(BUSINESS WIRE)–$DTIL #ARCUS–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS\u00ae-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that three abstracts have been accepted by the European Society of Gene & … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49463","6":"format-standard","7":"category-industry"},"yoast_head":"\nPrecision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"– Oral and Poster Presentations to Highlight Preclinical Research for ARCUS\u00ae Gene Editing DURHAM, N.C.–(BUSINESS WIRE)–$DTIL #ARCUS–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS\u00ae-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that three abstracts have been accepted by the European Society of Gene & ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-11T07:02:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221011005408\/en\/593587\/21\/Precision_BioSciences_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress\",\"datePublished\":\"2022-10-11T07:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/\"},\"wordCount\":373,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005408\\\/en\\\/593587\\\/21\\\/Precision_BioSciences_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/\",\"name\":\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005408\\\/en\\\/593587\\\/21\\\/Precision_BioSciences_logo.jpg\",\"datePublished\":\"2022-10-11T07:02:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005408\\\/en\\\/593587\\\/21\\\/Precision_BioSciences_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005408\\\/en\\\/593587\\\/21\\\/Precision_BioSciences_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/","og_locale":"en_US","og_type":"article","og_title":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress - Pharma Trend","og_description":"– Oral and Poster Presentations to Highlight Preclinical Research for ARCUS\u00ae Gene Editing DURHAM, N.C.–(BUSINESS WIRE)–$DTIL #ARCUS–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS\u00ae-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that three abstracts have been accepted by the European Society of Gene & ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-11T07:02:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221011005408\/en\/593587\/21\/Precision_BioSciences_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress","datePublished":"2022-10-11T07:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/"},"wordCount":373,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221011005408\/en\/593587\/21\/Precision_BioSciences_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/","url":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/","name":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221011005408\/en\/593587\/21\/Precision_BioSciences_logo.jpg","datePublished":"2022-10-11T07:02:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221011005408\/en\/593587\/21\/Precision_BioSciences_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221011005408\/en\/593587\/21\/Precision_BioSciences_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-29th-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49463"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49463\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}